MetLife Investment Management’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,390
| Closed | -$43K | – | 2823 |
|
|
2024
Q4 | $43K | Sell |
23,390
-7,508
| -24% | -$13.8K | ﹤0.01% | 2750 |
|
|
2024
Q3 | $107K | Sell |
30,898
-17,692
| -36% | -$61.2K | ﹤0.01% | 2597 |
|
|
2024
Q2 | $142K | Buy |
48,590
+18,306
| +60% | +$53.6K | ﹤0.01% | 2436 |
|
|
2024
Q1 | $171K | Buy |
30,284
+1,904
| +7% | +$10.8K | ﹤0.01% | 2278 |
|
|
2023
Q4 | $122K | Hold |
28,380
| – | – | ﹤0.01% | 2504 |
|
|
2023
Q3 | $98.5K | Hold |
28,380
| – | – | ﹤0.01% | 2585 |
|
|
2023
Q2 | $132K | Hold |
28,380
| – | – | ﹤0.01% | 2521 |
|
|
2023
Q1 | $131K | Hold |
28,380
| – | – | ﹤0.01% | 2442 |
|
|
2022
Q4 | $229K | Buy |
28,380
+4,303
| +18% | +$34.8K | ﹤0.01% | 2162 |
|
|
2022
Q3 | $134K | Buy |
24,077
+20,715
| +616% | +$115K | ﹤0.01% | 2536 |
|
|
2022
Q2 | $17.5K | Sell |
3,362
-22,141
| -87% | -$115K | ﹤0.01% | 2847 |
|
|
2022
Q1 | $210K | Buy |
25,503
+9,080
| +55% | +$74.6K | ﹤0.01% | 2329 |
|
|
2021
Q4 | $244K | Hold |
16,423
| – | – | ﹤0.01% | 1936 |
|
|
2021
Q3 | $310K | Hold |
16,423
| – | – | ﹤0.01% | 1805 |
|
|
2021
Q2 | $305K | Buy |
16,423
+3,340
| +26% | +$62.1K | ﹤0.01% | 1875 |
|
|
2021
Q1 | $298K | Buy |
13,083
+500
| +4% | +$11.4K | ﹤0.01% | 1815 |
|
|
2020
Q4 | $273K | Hold |
12,583
| – | – | ﹤0.01% | 1817 |
|
|
2020
Q3 | $126K | Buy |
+12,583
| New | +$126K | ﹤0.01% | 2104 |
|